D-Cycloserine destruction by alanine racemase and the limit of irreversible inhibition
Authors
de Chiara CHomsak M
Prosser, GA
Purkiss AG
Tate EW
de Carvalho LPS
Douglas, HL
Garza-garcia, A
Kelly, G
Affiliation
Mycobacterial Metabolism and Antibiotic Research Laboratory, The Francis Crick Institute, London, UK.Issue Date
2020
Metadata
Show full item recordCitation
Dunnett-Kane V, Burkitt-Wright E, Blackhall FH, Malliri A, Evans G, Lindsay CR. Germline and sporadic cancers driven by the RAS pathway: parallels and contrasts. Ann Oncol. 2020.Journal
Nature Chemical BiologyDOI
10.1038/s41589-020-0498-9PubMed ID
32203411Additional Links
https://dx.doi.org/10.1038/s41589-020-0498-9Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1038/s41589-020-0498-9